Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A
randomized, controlled trial of oral propranolol in infantile
hemangioma. N Engl...
Léauté-Labrèze C, Voisard JJ, Moore N. Oral propranolol for
infantile hemangioma. N Engl J Med. 2015;373(3):284–285. doi:
10.1056/NEJMc1502509.
Shah SD, Baselga E, McCuaig C, et al. Rebound growth of
infantile hemangiomas after propranolol therapy. Pediatrics.
2016;137(4):e20151754....
Pope E, Chakkittakandiyil A, Lara-Corrales I, et al. Expanding
the therapeutic repertoire of infantile hemangiomas: cohortblinded study of...
Kalsoom S, Zamir A, Rehman AU, et al. Clinical pharmacokinetics of nadolol: a systematic review. J Clin Pharm Ther. 2022;
47(10):1506–1516....
Pope E, Lara-Corrales I, Sibbald C, et al. Noninferiority
and safety of nadolol vs propranolol in infants with infantile
hemangioma: a randomized...
Colmenero-Sendra M, Del Boz-González J, Segura-Palacios JM,
et al. Nadolol for infantile hemangiomas previously treated
with propranolol....
Eichenfield LF, Friedlander SF, Baselga E, et al. Laser treatment
of ulcerated infantile hemangiomas. Pediatr Dermatol. 2018;35
(3):365–372....
Tollefson MM, Frieden IJ. Early intervention and combination
therapy for ulcerated hemangiomas: propranolol and pulsed
dye laser. J Am Acad...
McGillis E, Baumann T, LeRoy J. Death associated with nadolol
for infantile hemangioma: a case for improving safety.
Pediatrics. 2020;145(3):e20191035....
